This paper is in the following e-collection/theme issue:

Cyberpharmacies (45) JMIR Theme Issue: COVID-19 Special Issue (2452) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1517) Drug Repurposing and Off-Label Use (25) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (156) Infectious Diseases (non-STD/STI) (1575) Outbreak and Pandemic Preparedness and Management (1727) Information Seeking, Information Needs (465) Infoveillance and Social Listening (209)
Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27704, first published .
COVID-19 Treatments Sold Online Without Prescription Requirements in the United States: Cross-sectional Study Evaluating Availability, Safety and Marketing of Medications

COVID-19 Treatments Sold Online Without Prescription Requirements in the United States: Cross-sectional Study Evaluating Availability, Safety and Marketing of Medications

COVID-19 Treatments Sold Online Without Prescription Requirements in the United States: Cross-sectional Study Evaluating Availability, Safety and Marketing of Medications

Authors of this article:

Sachiko Ozawa1, 2 Author Orcid Image ;   Joanna Billings1 Author Orcid Image ;   Yujiao Sun1 Author Orcid Image ;   Sushan Yu1 Author Orcid Image ;   Benjamin Penley1 Author Orcid Image
Article Authors Cited by (16) Tweetations (4) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.